Log In
BCIQ
Print this Print this
 

GL-0810

  Manage Alerts
Collapse Summary General Information
Company Gliknik Inc.
DescriptionImmunomodulator
Molecular Target
Mechanism of ActionImmune modulation; Vaccine
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationHead and neck cancer
Indication DetailsTreat head and neck squamous cell carcinoma (HNSCC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today